Julie Faltum is an entrepreneurial and accomplished biopharmaceutical leader with deep and extensive experience in product development combining business and biology across strategic, commercial, BD, development and other leadership roles from Big Pharma including Novo Nordisk and Sanofi, from smaller biopharma companies and biotech from global and U.S. leadership roles as well as a strategic management consultant and advisor to startups.
Her passion is advancing treatment options that can make a difference in the lives of people with serious and underserved conditions and adding value to the healthcare ecosystem.
She is now using the breadth of her experience from the industry across multiple therapy areas from early-stage development to product launches to help companies solve key business challenges and unlock opportunities.
Julie holds an MSc. in International Business from Copenhagen Business School, a CEMS Master as well as a postgraduate degree in pharmaceutical medicine and drug development (ECPM) from University of Basel in Switzerland.